• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎谱系疾病中的 IL-10 产生调节性 B 细胞(B10 细胞)和调节性 T 细胞亚群。

The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.

机构信息

Department of Neurology, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, South Korea.

Department of Neurology, Bucheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, South Korea.

出版信息

Neurol Sci. 2018 Mar;39(3):543-549. doi: 10.1007/s10072-018-3248-y. Epub 2018 Jan 19.

DOI:10.1007/s10072-018-3248-y
PMID:29349658
Abstract

B cells contribute to the pathogenesis of neuromyelitis optica (NMO) by producing Aquaporin 4-specific autoantibodies (AQP4-ab); on the other hand, there are certain B cells that suppress immune responses by producing regulatory cytokines, such as IL-10. In this study, we investigated the presence of IL-10-producing Breg cells among lymphocyte subsets. Twenty-two seropositive NMO spectrum disorder (NMOSD) patients (29 samples) and 13 healthy controls (HCs) (14 samples) were enrolled. All NMOSD patients have received one or more immunosuppressive drugs. The phenotype and frequency of B cell and T cell subsets in the peripheral blood were measured by flow cytometry. We defined Breg cells as IL-10-producing B (B10) cells, which are CD19CD39CD1dIL-10. The potential relations were evaluated between specific lymphocyte subsets and AQP4-ab intensity measured by the cell-based indirect immunofluorescence assay. The frequency of B10 cells was higher in patients with NMOSD regardless of the disease status than that in HCs (attack samples; p = 0.009 and remission samples; p < 0.001, respectively). In addition, the frequency of IL-17 Treg cells among Treg cells was higher during remission than during an attack (uncorrected p = 0.032). Among the lymphocyte subsets, B10 cells alone showed a positive correlation with the intensity of AQP4-ab positivity (ρ [rho] = 0.402 and p = 0.031). It was suggested that the suppressive subsets including B10 and IL-17 Treg cells might have important roles in controlling disease status in NMOSD. Further functional studies may help to elucidate the immunological role of B10 and IL-17 Treg cells in NMOSD.

摘要

B 细胞通过产生水通道蛋白 4 特异性自身抗体(AQP4-ab)参与视神经脊髓炎(NMO)的发病机制;另一方面,某些 B 细胞通过产生调节细胞因子(如 IL-10)来抑制免疫反应。在这项研究中,我们研究了淋巴细胞亚群中是否存在产生 IL-10 的 Breg 细胞。共纳入 22 例血清阳性 NMO 谱障碍(NMOSD)患者(29 份样本)和 13 名健康对照者(HCs)(14 份样本)。所有 NMOSD 患者均接受过一种或多种免疫抑制剂治疗。通过流式细胞术测量外周血 B 细胞和 T 细胞亚群的表型和频率。我们将 Breg 细胞定义为产生 IL-10 的 B 细胞(B10),其特征为 CD19+CD39+CD1d+IL-10+。通过基于细胞的间接免疫荧光测定评估特定淋巴细胞亚群与 AQP4-ab 强度之间的潜在关系。NMOSD 患者无论疾病状态如何,B10 细胞的频率均高于 HCs(攻击样本:p=0.009;缓解样本:p<0.001)。此外,在缓解期,Treg 细胞中的 IL-17 Treg 细胞频率高于发作期(未校正 p=0.032)。在淋巴细胞亚群中,只有 B10 细胞与 AQP4-ab 阳性强度呈正相关(ρ[rho]=0.402,p=0.031)。提示包括 B10 和 IL-17 Treg 细胞在内的抑制性亚群可能在控制 NMOSD 的疾病状态方面发挥重要作用。进一步的功能研究可能有助于阐明 B10 和 IL-17 Treg 细胞在 NMOSD 中的免疫作用。

相似文献

1
The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.视神经脊髓炎谱系疾病中的 IL-10 产生调节性 B 细胞(B10 细胞)和调节性 T 细胞亚群。
Neurol Sci. 2018 Mar;39(3):543-549. doi: 10.1007/s10072-018-3248-y. Epub 2018 Jan 19.
2
Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.CD40/CD40L信号传导对中国过敏性紫癜性肾炎患儿中产生白细胞介素-10的调节性B细胞的影响。
Immunol Res. 2017 Jun;65(3):592-604. doi: 10.1007/s12026-016-8877-8.
3
Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.视神经脊髓炎中循环 B 细胞水通道蛋白 4 抗体的条件依赖性产生。
Brain. 2018 Apr 1;141(4):1063-1074. doi: 10.1093/brain/awy010.
4
The imbalance between regulatory and memory B cells accompanied by an increased number of circulating T-follicular helper cells in MOG-antibody-associated demyelination.在髓鞘少突胶质细胞糖蛋白抗体相关脱髓鞘中,调节性 B 细胞和记忆 B 细胞失衡,同时伴有循环滤泡辅助性 T 细胞数量增加。
Mult Scler Relat Disord. 2019 Nov;36:101397. doi: 10.1016/j.msard.2019.101397. Epub 2019 Sep 16.
5
Regulatory B cells in ANCA-associated vasculitis.抗中性粒细胞胞质抗体相关性血管炎中的调节性 B 细胞。
Ann Rheum Dis. 2013 Aug;72(8):1416-9. doi: 10.1136/annrheumdis-2012-202986. Epub 2013 May 10.
6
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.根据抗水通道蛋白 4 抗体状况,日本视神经脊髓炎患者具有不同的遗传和感染特征。
J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):29-34. doi: 10.1136/jnnp-2012-302925. Epub 2012 Oct 4.
7
[Proportion and significance of CD1d(hi)CD5⁺CD19⁺ regulatory B cell in peripheral blood of patients with neuromyelitis optica].视神经脊髓炎患者外周血中CD1d(hi)CD5⁺CD19⁺调节性B细胞的比例及意义
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Mar;31(3):375-8.
8
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.系统性红斑狼疮患者视神经脊髓炎病程中自身抗体和细胞因子反应的变化:一项初步研究。
Mult Scler. 2016 Aug;22(9):1192-201. doi: 10.1177/1352458515613165. Epub 2015 Oct 29.
9
Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.视神经脊髓炎谱系疾病患者循环调节性 B 细胞亚群。
Neurol Sci. 2017 Jul;38(7):1205-1212. doi: 10.1007/s10072-017-2932-7. Epub 2017 Apr 7.
10
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.免疫球蛋白和利妥昔单抗治疗视神经脊髓炎急性发作后B细胞和T细胞亚群及NMO-IgG水平的变化
Neurologia. 2015 Jun;30(5):276-82. doi: 10.1016/j.nrl.2013.12.022. Epub 2014 Mar 24.

引用本文的文献

1
Association between polymorphisms and expression and neuromyelitis optica spectrum disorder risk in the Northern Chinese Han population.中国北方汉族人群中多态性与表达及视神经脊髓炎谱系障碍风险之间的关联。
Transl Neurosci. 2024 Apr 5;15(1):20220337. doi: 10.1515/tnsci-2022-0337. eCollection 2024 Jan 1.
2
Intruders or protectors - the multifaceted role of B cells in CNS disorders.入侵者还是保护者——B细胞在中枢神经系统疾病中的多面角色
Front Cell Neurosci. 2024 Jan 10;17:1329823. doi: 10.3389/fncel.2023.1329823. eCollection 2023.
3
Association of plasma sPD-1 and sPD-L1 with disease status and future relapse in AQP4-IgG (+) NMOSD.

本文引用的文献

1
Phenotypic and functional characteristics of CD39 human regulatory B cells (Breg).CD39人调节性B细胞(Breg)的表型和功能特征。
Oncoimmunology. 2016 Feb 26;5(2):e1082703. doi: 10.1080/2162402X.2015.1082703. eCollection 2016 Feb.
2
Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients.多发性硬化症患者的血液B细胞和调节亚群含量
J Mult Scler (Foster City). 2015 May;2(2). doi: 10.4172/2376-0389.1000139.
3
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.视神经脊髓炎谱系障碍国际共识诊断标准
血清 sPD-1 和 sPD-L1 与 AQP4-IgG(+) NMOSD 疾病状态和未来复发的相关性。
Ann Clin Transl Neurol. 2024 Feb;11(2):436-449. doi: 10.1002/acn3.51964. Epub 2023 Dec 8.
4
Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder.初诊 BMI 对视神经脊髓炎谱系疾病临床表现和预后的影响。
Ann Clin Transl Neurol. 2023 Sep;10(9):1673-1681. doi: 10.1002/acn3.51857. Epub 2023 Jul 26.
5
Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems. Toll 样受体在神经免疫性疾病中的作用:治疗靶点和问题。
Front Immunol. 2021 Nov 1;12:777606. doi: 10.3389/fimmu.2021.777606. eCollection 2021.
6
A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder.《遗传因素在视神经脊髓炎谱系疾病中的作用的全面综述》
Front Immunol. 2021 Oct 5;12:737673. doi: 10.3389/fimmu.2021.737673. eCollection 2021.
7
Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.调节性 T 细胞通过减轻视神经脊髓炎谱系疾病中的炎症反应来保护大脑免受损伤。
J Neuroinflammation. 2021 Sep 15;18(1):201. doi: 10.1186/s12974-021-02266-0.
8
Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD.细胞疗法:治疗 NMOSD 和 MOGAD 的新兴基于细胞的治疗方法。
Int J Mol Sci. 2021 Jul 25;22(15):7925. doi: 10.3390/ijms22157925.
9
Emerging therapeutic targets for neuromyelitis optica spectrum disorder.视神经脊髓炎谱系疾病的新兴治疗靶点。
Expert Opin Ther Targets. 2020 Mar;24(3):219-229. doi: 10.1080/14728222.2020.1732927. Epub 2020 Mar 2.
10
Triglyceride Level Is an Independent Risk Factor in First-Attacked Neuromyelitis Optica Spectrum Disorders Patients.甘油三酯水平是初发视神经脊髓炎谱系障碍患者的独立危险因素。
Front Neurol. 2019 Nov 21;10:1230. doi: 10.3389/fneur.2019.01230. eCollection 2019.
Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.
4
B lymphocytes in neuromyelitis optica.视神经脊髓炎中的 B 淋巴细胞。
Neurol Neuroimmunol Neuroinflamm. 2015 May 7;2(3):e104. doi: 10.1212/NXI.0000000000000104. eCollection 2015 Jun.
5
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.人类炎症性和自身免疫性疾病中的调节性B细胞:从小鼠模型到临床研究
Int Immunol. 2015 Oct;27(10):495-504. doi: 10.1093/intimm/dxv026. Epub 2015 May 8.
6
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.视神经脊髓炎中记忆性B细胞与调节性B细胞之间的免疫平衡以及甲泼尼龙或利妥昔单抗治疗后该平衡的变化。
J Neuroimmunol. 2015 May 15;282:45-53. doi: 10.1016/j.jneuroim.2015.03.016. Epub 2015 Mar 21.
7
Regulatory B cells: origin, phenotype, and function.调节性 B 细胞:起源、表型和功能。
Immunity. 2015 Apr 21;42(4):607-12. doi: 10.1016/j.immuni.2015.04.005.
8
B10 cells: a functionally defined regulatory B cell subset.B10细胞:一种功能上定义的调节性B细胞亚群。
J Immunol. 2015 Feb 15;194(4):1395-401. doi: 10.4049/jimmunol.1401329.
9
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.多发性硬化症患者中调节性B细胞频率和功能未改变。
Clin Immunol. 2014 Dec;155(2):198-208. doi: 10.1016/j.clim.2014.09.011. Epub 2014 Sep 28.
10
Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity.调节性B细胞的变化及其与类风湿性关节炎疾病活动的关系。
Clin Exp Med. 2015 Aug;15(3):285-92. doi: 10.1007/s10238-014-0310-9. Epub 2014 Sep 23.